FDA Approved: EPOPROSTENOL — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved Gland Pharma Limited's epoprostenol under Original Application (ANDA 219237). The drug is indicated for the treatment of pulmonary arterial hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Epoprostenol (Epoprostenol)

Snippet

ORIG AP for EPOPROSTENOL (EPOPROSTENOL)